ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Donors with Isolated Anti-HBc (“HBcAb Only”) Antibodies: True Evidence for Past Infection or Laboratory Artifact? Toward a Simple Confirmatory Test for HBcAb.

Y. Chang,1,3 C. Chinchilla-Reyes,2 M. Koss,1,2 M. Nowicki.1,2

1Mendez National Institute of Transplantation Foundation, Los Angeles, CA
2Viracor-IBT Laboratories, Los Angeles, CA
3Western University of Health Sciences, Pomona, CA.

Meeting: 2016 American Transplant Congress

Abstract number: 71

Keywords: Cadaveric organs, Hepatitis B, Safety, Screening

Session Information

Date: Sunday, June 12, 2016

Session Name: Concurrent Session: SOT: HIV, HBV, & HCV

Session Time: 2:30pm-4:00pm

 Presentation Time: 2:54pm-3:06pm

Location: Room 313

Related Abstracts
  • Comparison of QuantiFERON-TB Gold with Tuberculin Skin Test for Detecting Latent Tuberculosis Infection before Kidney Transplantation
  • West Nile Virus (WNV) Epidemic during 2012 in the Western United States: High Number of IgM Anti-WNV Reactives but No WNV RNA+ Organ Donors

Use of organs from donors positive for hepatitis B virus (HBV) markers may safely expand the donor pool. Recently the American Society of Transplantation expert panel recommended that organs from “HBcAb only” donors be considered for transplantation with antiviral HBV prophylaxis (AJT, May, 2015). The HBV prophylaxis is a long-term treatment, with side effects, and is expensive. However, based upon epidemiological and vaccine studies it was determined that for 50% of these individuals HBcAb results could be false positive and only could be resolved with the elaborate algorithms. These algorithms are not feasible for organ donor testing, and there is no commercial confirmatory test for HBcAb.

Aim: To develop a supplemental assay for resolving questionable HBcAb+ cases among organ donors.

Methods: To develop the HBcAb neutralization assay, we used WHO HBcAb standard, recombinant HBcAg, and recombinant HCV core antigen as specificity control. Tested serum was incubated 1:20 with rHBcAg or rHCcAg or mock buffer for 1hr/37oC, and tested using HBcAb screening assay. Neutralization ≥ 50% was considered significant.

Results: Our neutralization protocol was reproducible, robust, and showed specific inhibition of HBcAb (figure). When applied to well-characterized specimens from donors, sera with weak HBsAb reactivity or with HBcAb as the only marker showed no neutralization. In contrast, almost all donors with strong HBcAb and HBsAb co-reactivity showed significant neutralization.

Conclusions: We developed a simple neutralization procedure to confirm the specificity of HBcAb. Our preliminary data suggests that significant proportion of “HBcAb only” donors could be false positive. Inclusion of the HBcAb neutralization test in testing protocol could help resolve questionable HBcAb, prevent unnecessary post-transplant preventive anti-HBV treatment, and contribute to better organ utilization.

CITATION INFORMATION: Chang Y, Chinchilla-Reyes C, Koss M, Nowicki M. Donors with Isolated Anti-HBc (“HBcAb Only”) Antibodies: True Evidence for Past Infection or Laboratory Artifact? Toward a Simple Confirmatory Test for HBcAb. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Chang Y, Chinchilla-Reyes C, Koss M, Nowicki M. Donors with Isolated Anti-HBc (“HBcAb Only”) Antibodies: True Evidence for Past Infection or Laboratory Artifact? Toward a Simple Confirmatory Test for HBcAb. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/donors-with-isolated-anti-hbc-hbcab-only-antibodies-true-evidence-for-past-infection-or-laboratory-artifact-toward-a-simple-confirmatory-test-for-hbcab/. Accessed January 18, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • How To Handle a Missed or Delayed Dose Intake? A Pharmacokinetic Study of Cyclosporine and Tacrolimus in Renal Transplant Patients
  • Hyperkalemia in the Early Post Renal Transplant Period

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.